Schedule Killed Pfizer IP Suit, AntiCancer Tells Fed. Circ.
California biotech firm AntiCancer Inc. on Tuesday asked the Federal Circuit to revive its suit accusing Pfizer Inc. and Crown BioScience Inc. of infringing cancer imaging patents, saying local patent rules...To view the full article, register now.
Already a subscriber? Click here to view full article